Fetzima 120 mg (Levomilnacipran (Levomilnacipran Hydrochloride) CAPSULE (EXTENDED RELEASE)) 120 MG

Fetzima 120 mg is an extended-release capsule containing levomilnacipran hydrochloride, used for managing certain mood disorders. This medication is designed to provide sustained relief and is manufactured by AbbVie Corporation in Canada.

Strength

120 MG

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fetzima 120 mg is primarily used to help manage symptoms of major depressive disorder (MDD). This medication works by affecting the balance of natural substances in the brain, which may help improve mood and emotional well-being. People often ask, 'What is Fetzima used for?' and the answer is that it is typically prescribed for adults experiencing depressive episodes.

Side Effects

Common effects of Fetzima 120 mg may include changes in appetite, sleep patterns, and energy levels. Some users may experience mild nausea or dizziness, especially when first starting the medication. These effects are generally temporary and may subside as the body adjusts to the medication.

Precautions & Warnings

Fetzima 120 mg should be handled with care, especially if you have a history of certain medical conditions such as heart problems or high blood pressure. It is important to follow the advice of a healthcare provider regarding the use of this medication. Always store Fetzima in a cool, dry place away from direct sunlight.

Avoid Interactions

Fetzima 120 mg may interact with other medications, including those that affect serotonin levels or blood pressure. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol should be avoided while taking Fetzima, as it may increase the risk of side effects.

Frequently Asked Questions

Fetzima 120 mg is used to manage symptoms of major depressive disorder (MDD) in adults.

Fetzima 120 mg is an extended-release capsule that should be taken orally, usually once daily, with or without food.

Common side effects may include changes in appetite, sleep patterns, nausea, and dizziness.

It is generally advised to avoid alcohol while taking Fetzima, as it may increase the risk of side effects.

Fetzima 120 mg should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.